TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18724016

Group type: EXPERIMENTAL
Intervention: Nicorandil Group (n=37)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control Group (n=36)
Number of subjects: 73
Study: 18259010

Group type: EXPERIMENTAL
Intervention: Superimposed preeclampsia
Number of subjects: 822
Study: 15462619

Group type: EXPERIMENTAL
Intervention: Repeatedly conflict with each other
Number of subjects: 0

Group type: COMPARATOR
Intervention: Repeatedly passed safely
Number of subjects: 0
Study: 11443189

Group type: EXPERIMENTAL
Intervention: leuprolide with ipriflavone
Number of subjects: 102

Group type: COMPARATOR
Intervention: leuprolide only
Number of subjects: 102
Study: 9223362

Group type: EXPERIMENTAL
Intervention: Cold-blood cardioplegia containing 1 mM adenosine
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo (standard cold-blood cardioplegia)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo (100 microM adenosine)
Number of subjects: 61
Study: 7958119

Group type: EXPERIMENTAL
Intervention: Aerosolized salbutamol (200 micrograms)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Combination dose aerosol of fenoterol hydrobromide (200 micrograms) and ipratropium bromide (80 micrograms)
Number of subjects: 10
Study: 3314464

Group type: EXPERIMENTAL
Intervention: Metoprolol 100 mg administered twice daily
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 31530820

Group type: EXPERIMENTAL
Intervention: Group OA (obesity patients with metabolic diseases)
Number of subjects: 1914

Group type: EXPERIMENTAL
Intervention: Group O (obesity patients without metabolic diseases)
Number of subjects: 1914

Group type: EXPERIMENTAL
Intervention: Group OA
Number of subjects: 1914

Group type: EXPERIMENTAL
Intervention: Common biomarkers for obesity patients with high uric acid, high serum lipids, and high blood pressure
Number of subjects: 1914

Group type: EXPERIMENTAL
Intervention: Blautia, Romboutsia, Ruminococcus2, Clostridium sensu stricto, Dorea
Number of subjects: 1914

Group type: EXPERIMENTAL
Intervention: Bacteroides, Roseburia, Butyricicoccus, Alistipes, Parasutterella, Parabacteroides, Clostridium IV
Number of subjects: 1914
Study: 29946969

Group type: EXPERIMENTAL
Intervention: Reactive jumps countermeasure (JUMP)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (CTRL)
Number of subjects: 22
Study: 26573073

Group type: EXPERIMENTAL
Intervention: Prophylactic minocycline (100 mg twice per day for 4 weeks)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Reactive treatment (after rash developed, per grade of rash)
Number of subjects: 150

Group type: COMPARATOR
Intervention: No treatment unless severe (grade 3)
Number of subjects: 150
Study: 24496086

Group type: EXPERIMENTAL
Intervention: Stellate ganglion block (SGB) with 5 mL of 0.5% bupivacaine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham injection of saline
Number of subjects: 40
Study: 22562434

Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition (TPN) with long-chain triglycerides (LCTs)
Number of subjects: 50

Group type: COMPARATOR
Intervention: LCTs plus medium-chain triglycerides (MCTs) as 50/50
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: LCTs
Number of subjects: 50
Study: 20173436

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg ketamine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Isotonic saline
Number of subjects: 60
Study: 18073339

Group type: EXPERIMENTAL
Intervention: Multilevel intervention promoting physical activity and healthy eating
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Leadership involvement through key informant interviews and advisory boards
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Employee focus groups and advisory boards
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quantitative environmental assessments
Number of subjects: 0
Study: 15704506

Group type: EXPERIMENTAL
Intervention: 12-week home-based trunk-strengthening exercise programme
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 28
Study: 12235653

Group type: EXPERIMENTAL
Intervention: Soy (100 g/day)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Tea extract (3 g/day)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Vegetables (400 g/day as 134 g broccoli, 134 g brussels sprouts, and 134 g petits pois)
Number of subjects: 11

Group type: COMPARATOR
Intervention: High red meat diet (420 g/day)
Number of subjects: 11
Study: 10460065

Group type: EXPERIMENTAL
Intervention: Grapefruit juice (200 mL, double-strength, three times a day for 2 days) with atorvastatin (40 mg)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Grapefruit juice (200 mL, double-strength, three times a day for 2 days) with pravastatin (40 mg)
Number of subjects: 23
Study: 7543131

Group type: EXPERIMENTAL
Intervention: Diet advice (D, n = 40)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Exercise advice (E, n = 39)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Combination of diet and exercise advice (DE, n = 39)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Control group (C, n = 39)
Number of subjects: 157
Study: 2523528

Group type: EXPERIMENTAL
Intervention: 75 mg triamcinolone diacetate (TR)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 8 mg of preservative-free morphine (MP)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Both triamcinolone and morphine (TR and MP)
Number of subjects: 22
Study: 974610

Group type: EXPERIMENTAL
Intervention: Oxprenolol (beta-blocking agent)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 31373537

Group type: COMPARATOR
Intervention: TG1050 (109, 1010, 1011 virus particles)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: TG1050 (1010 virus particles)
Number of subjects: 48

Group type: COMPARATOR
Intervention: TG1050
Number of subjects: 48
Study: 31402112

Group type: EXPERIMENTAL
Intervention: Mechanical and oral antibiotic bowel preparation (MOABP)
Number of subjects: 396

Group type: COMPARATOR
Intervention: No bowel preparation (NBP)
Number of subjects: 396
Study: 28655522

Group type: EXPERIMENTAL
Intervention: Diet plus pravastatin
Number of subjects: 3397

Group type: COMPARATOR
Intervention: Diet alone
Number of subjects: 3397
Study: 25751506

Group type: EXPERIMENTAL
Intervention: Seasonal WIV vaccine (sWIV) - one dose
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pandemic WIV vaccine (pWIV) - two doses
Number of subjects: 0

Group type: COMPARATOR
Intervention: Commercially available trivalent comparator vaccine - one dose followed by placebo
Number of subjects: 0
Study: 23395192

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Social Skills Training (CBSST)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Goal-Focused Supportive Contact (GFSC)
Number of subjects: 79
Study: 21954992

Group type: EXPERIMENTAL
Intervention: GP ablation plus PVI or Maze
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: GP ablation alone
Number of subjects: 342
Study: 19203569

Group type: EXPERIMENTAL
Intervention: 1 mg test formulation of risperidone
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 2 mg test formulation of risperidone
Number of subjects: 30

Group type: COMPARATOR
Intervention: 1 mg reference formulation of risperidone
Number of subjects: 30

Group type: COMPARATOR
Intervention: 2 mg reference formulation of risperidone
Number of subjects: 30
Study: 17540193

Group type: EXPERIMENTAL
Intervention: Nesiritide (28-day continuous infusion)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo (28-day continuous infusion)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Nesiritide
Number of subjects: 120
Study: 16734116

Group type: EXPERIMENTAL
Intervention: S. mansoni calreticulin (SmCaR)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Soluble adult worm antigen (SAWA)
Number of subjects: 30
Study: 15213581

Group type: COMPARATOR
Intervention: Methylphenidate alone
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Methylphenidate plus psychosocial treatment (parent training, counseling, social skills training, psychotherapy, academic assistance)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Methylphenidate plus attention psychosocial control treatment
Number of subjects: 103
Study: 11181810

Group type: EXPERIMENTAL
Intervention: Moxonidine (0.2 mg twice a day)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 9164420

Group type: EXPERIMENTAL
Intervention: Befunolol
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Metipranolol
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Timolol
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Dipivefrin
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Betaxolol
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Levobunolol
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Pilocarpine
Number of subjects: 10
Study: 8220653

Group type: EXPERIMENTAL
Intervention: 60 mg fluoxetine (FXT)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Carbohydrate (CHO) breakfast (80 g maltodextrin, 300 kcal)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Protein-rich (PROT) breakfast (60% milk protein and 40% CHO, 300 kcal)
Number of subjects: 38
Study: 3114812

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of physostigmine for 2 h
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (isotonic glucose)
Number of subjects: 10
Study: 30071838

Group type: EXPERIMENTAL
Intervention: Combination of at least three different classes of psychiatric drugs
Number of subjects: 1653

Group type: COMPARATOR
Intervention: FGA alone therapy
Number of subjects: 1653

Group type: COMPARATOR
Intervention: SGA use
Number of subjects: 1653

Group type: COMPARATOR
Intervention: Combination of drugs from two different classes
Number of subjects: 1653
Study: 26919829

Group type: EXPERIMENTAL
Intervention: Chronic upper limb pain group
Number of subjects: 82

Group type: COMPARATOR
Intervention: Pain-free controls
Number of subjects: 82
Study: 25664643

Group type: EXPERIMENTAL
Intervention: Intensive skill-based intervention
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Low-intensity intervention
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Relationship education programs
Number of subjects: 130
Study: 23845658

Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 75

Group type: COMPARATOR
Intervention: Methadone
Number of subjects: 75
Study: 21384106

Group type: EXPERIMENTAL
Intervention: 4 mg/kg caffeine
Number of subjects: 20

Group type: COMPARATOR
Intervention: 0 mg/kg caffeine
Number of subjects: 20
Study: 18417099

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Zopiclone
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 16847198

Group type: EXPERIMENTAL
Intervention: Psoralen-UV-A (PUVA) therapy
Number of subjects: 93

Group type: COMPARATOR
Intervention: Narrowband UV-B (NB-UVB) therapy
Number of subjects: 93
Study: 12700623

Group type: EXPERIMENTAL
Intervention: Mediterranean diet (increased consumption of fish, fruit, raw and cooked vegetables, and olive oil)
Number of subjects: 11323

Group type: EXPERIMENTAL
Intervention: Dietary advice to increase Mediterranean food consumption
Number of subjects: 11323
Study: 11094366

Group type: EXPERIMENTAL
Intervention: Jones jig appliance
Number of subjects: 72

Group type: COMPARATOR
Intervention: Cervical headgear
Number of subjects: 72
Study: 8636825

Group type: EXPERIMENTAL
Intervention: 1‐24ACTH stimulation testing (0.1 microgram/kg)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: 1‐24ACTH stimulation testing (0.2 microgram/kg)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Baseline cortisol concentrations < 414 nmol/L (15.0 micrograms/dl)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Response to 1‐24ACTH
Number of subjects: 67
Study: 1473127

Group type: EXPERIMENTAL
Intervention: Fish oil (15 ml/d, equivalent to 3.1 g of n-3 fatty acid per day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (15 ml/d saline)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Fish oil
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 6741670

Group type: EXPERIMENTAL
Intervention: Female smokers during separate and combined presentation of distractors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Female smokers during task-induced distraction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Task and combined noise- and task-induced distraction
Number of subjects: 0
Study: 31087608

Group type: EXPERIMENTAL
Intervention: Walnut consumption (48g walnuts in a smoothie)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo smoothie (macronutrient-matched without nuts)
Number of subjects: 10
Study: 28931520

Group type: EXPERIMENTAL
Intervention: 3 mg HIV-MAG DNA vaccine coadministered with pIL-12 at 0, 250, 1,000, or 1,500 μg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 3 mg HIV-MAG DNA vaccine coadministered with pIL-12 at low and medium doses
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: VSV-Gag vaccine boost
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: DNA prime with high-dose pIL-12
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: High-dose pIL-12 with DNA prime
Number of subjects: 100
Study: 25204714

Group type: EXPERIMENTAL
Intervention: Topical lidocaine
Number of subjects: 25

Group type: COMPARATOR
Intervention: Nonanesthetized condition
Number of subjects: 25
Study: 23325716

Group type: COMPARATOR
Intervention: Control condition (CON)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Exercise protocol (EP)
Number of subjects: 9
Study: 21411093

Group type: EXPERIMENTAL
Intervention: bezafibrate
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: fenofibrate
Number of subjects: 14
Study: 18775100

Group type: EXPERIMENTAL
Intervention: Flaxseed-derived lignan capsules (360 mg/d)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 17243014

Group type: EXPERIMENTAL
Intervention: Internet-delivered targeted group intervention (n=36), 6 sessions of 90 minutes each
Number of subjects: 73

Group type: COMPARATOR
Intervention: Delayed treatment control group (n=37)
Number of subjects: 73
Study: 15770057

Group type: EXPERIMENTAL
Intervention: Ozonated autohemotherapy (ozone concentration of 50 microg/ml)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control autohemotherapy (blood exposure to oxygen)
Number of subjects: 12
Study: 12099928

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen (HBO) breathing at 2.8 ATA for 15 min
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Normobaric oxygen (NBO) breathing
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen (HBO) breathing
Number of subjects: 16
Study: 10453777

Group type: EXPERIMENTAL
Intervention: Psychophysical testing (PT)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Laryngeal adductor reflex (LAR)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Total sample
Number of subjects: 100
Study: 7799018

Group type: EXPERIMENTAL
Intervention: Paclitaxel administered at 135 mg/m2 by 3-hour infusion
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Paclitaxel administered at 175 mg/m2 by 24-hour infusion
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Paclitaxel administered at 225 mg/m2 by 3-hour infusion
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Duration that plasma concentrations of paclitaxel > or = 0.05 mumol/L
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Pharmacokinetic model for paclitaxel disposition
Number of subjects: 30
Study: 2402844

Group type: EXPERIMENTAL
Intervention: Transcutaneous oestradiol for four months supplemented by medroxyprogesterone (Perlutex) from the 12th to 26th day of every month
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Transcutaneous oestradiol treatment
Number of subjects: 34
Study: 380533

Group type: EXPERIMENTAL
Intervention: Use of a 0.5-mm larger trephine on the donor
Number of subjects: 46

Group type: COMPARATOR
Intervention: Same size trephine on both donor and recipient
Number of subjects: 46
Study: 6859585

Group type: EXPERIMENTAL
Intervention: Nitrous-oxide-isoflurane (0.75-1.5% inspired)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Nitrous-oxide-fentanyl
Number of subjects: 20
Study: 31086034

Group type: EXPERIMENTAL
Intervention: 35 g enzymatically hydrolyzed collagen protein (EHC)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 35 g non-enzymatically hydrolyzed collagen protein (NC)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (250 mL water)
Number of subjects: 10
Study: 30440816

Group type: EXPERIMENTAL
Intervention: Deep sleep intervention
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Shallow sleep intervention
Number of subjects: 14

Group type: COMPARATOR
Intervention: Non‐intervention
Number of subjects: 14
Study: 27085834

Group type: EXPERIMENTAL
Intervention: LASMIV with delivery of the testis and ligature of collateral and gubernacular veins
Number of subjects: 70

Group type: COMPARATOR
Intervention: LASMIV without delivery of the testis
Number of subjects: 70
Study: 25456576

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC) - 3 cycles of cuff inflation to 200 mm Hg for 5 min, separated by 5 min deflation intervals.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group - blood pressure cuff remained deflated.
Number of subjects: 60
Study: 23046782

Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CT)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 132
Study: 20487354

Group type: EXPERIMENTAL
Intervention: Female-specific psychosocial intervention
Number of subjects: 29

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 29
Study: 19147974

Group type: EXPERIMENTAL
Intervention: Physical activity and exercise level assessed by questionnaire, maximum strength of the legs and aerobic capacity
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: Hand-grip strength
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: Weight
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: Lean body mass
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: Habitual physical activity
Number of subjects: 299
Study: 15702199

Group type: EXPERIMENTAL
Intervention: Independence estimating equations (IEE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Generalized estimating equations (GEE)
Number of subjects: 0
Study: 11714591

Group type: EXPERIMENTAL
Intervention: Greater abstinence-specific structural support (fewer drug users in the social network)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Decreases in negative abstinence-specific functional support (Complaints about Drug Use, Drug Exposure, and Demoralization)
Number of subjects: 128

Group type: COMPARATOR
Intervention: General support (structural or functional)
Number of subjects: 128
Study: 8993250

Group type: EXPERIMENTAL
Intervention: Heparin-coated cardiopulmonary bypass surface (Duraflo II)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Uncoated cardiopulmonary bypass surface
Number of subjects: 24
Study: 8181028

Group type: EXPERIMENTAL
Intervention: Vasodilator therapy (hydralazine-isosorbide dinitrate)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Angiotensin converting enzyme inhibitors
Number of subjects: 0
Study: 2955799

Group type: EXPERIMENTAL
Intervention: Orgotein (4 or 8 mg) injected 15 min after each daily radiation treatment
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Orgotein (4 or 8 mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Radiation treatment (63 Gy in 30 fractions)
Number of subjects: 30
Study: 29866187

Group type: EXPERIMENTAL
Intervention: Isolated soy protein + flaxseed oil (ISP + FO)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Isolated soy protein + corn oil (ISP + CO)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control (wheat flour + corn oil)
Number of subjects: 73
Study: 27324534

Group type: EXPERIMENTAL
Intervention: Heated humidified high-flow nasal cannula (HHHFNC)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Nasal continuous positive airway pressure (nCPAP)
Number of subjects: 161
Study: 24307502

Group type: EXPERIMENTAL
Intervention: Parenteral perioperative antimicrobials (Group I)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Extended oral antimicrobials for 8 days postoperatively (Group II)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group (Group I)
Number of subjects: 78
Study: 22382787

Group type: EXPERIMENTAL
Intervention: Trospium chloride capsule (20 mg, test)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Trospium chloride tablet (20 mg, reference)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Comparison of test and reference
Number of subjects: 20
Study: 20560981

Group type: EXPERIMENTAL
Intervention: fenofibrate 160 mg daily for 8 weeks
Number of subjects: 14

Group type: COMPARATOR
Intervention: no treatment for 8 weeks (control)
Number of subjects: 14
Study: 17556347

Group type: EXPERIMENTAL
Intervention: Prehospital fibrinolysis
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Facilitated PCI
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Facilitated PCI with TIMI 0‐1
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Incomplete STR < 70%
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Time‐to‐treatment delay
Number of subjects: 135
Study: 16386608

Group type: EXPERIMENTAL
Intervention: Basiliximab
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 15
Study: 12407040

Group type: EXPERIMENTAL
Intervention: 0.4 mg oral misoprostol twice daily (days 4-10)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: 0.8 mg vaginal misoprostol and placebo
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 9674003

Group type: EXPERIMENTAL
Intervention: ketorolac tromethamine 0.5%
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: diclofenac sodium 0.1%
Number of subjects: 58

Group type: COMPARATOR
Intervention: prednisolone acetate 1%
Number of subjects: 58
Study: 7979285

Group type: EXPERIMENTAL
Intervention: Valaciclovir 1,000 mg four times daily for 30 days
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Valaciclovir 2,000 mg four times daily for 30 days
Number of subjects: 2